Today: 21 March 2026
Subscribe
Browse Category

NASDAQ:INM 20 November 2025

InMed Pharmaceuticals (INM) Soars on Alzheimer’s Breakthrough: INM‑901 Study Sparks 20%+ Stock Rally on November 20, 2025

InMed Pharmaceuticals (INM) Soars on Alzheimer’s Breakthrough: INM‑901 Study Sparks 20%+ Stock Rally on November 20, 2025

InMed Pharmaceuticals shares surged over 20% in after-hours and pre-market trading following new preclinical data for its Alzheimer’s candidate INM-901. The company reported successful large-animal studies showing robust bioavailability and no adverse neurological effects. INM traded in the $1.49–$1.55 range Thursday morning on heavy volume, with market cap estimates between $3–5 million.
20 November 2025
···

Stock Market Today

  • Jury Holds Elon Musk Responsible for Twitter Stock Drop During 2022 Buyout
    March 20, 2026, 10:30 PM EDT. A California jury ruled Elon Musk responsible for the decline in Twitter's stock price during his 2022 bid to acquire the company for $44 billion. Musk was found to have publicly disparaged Twitter, alleging bot issues to pressure the stock price lower and negotiate a better deal. While Musk denies wrongdoing, his comments led to significant market impact, including a sharp 20% drop after he paused the purchase. Jurors confirmed two of four fraud claims but rejected a charge of a defrauding scheme. Musk's legal team plans to appeal. The ruling could force Musk to pay potentially billions of dollars to affected investors, marking a rare legal setback for the billionaire, whose net worth stands at $661 billion.
Go toTop